Voltage-gated potassium channel Kv1.3 is highly expressed in human osteosarcoma and promotes osteosarcoma growth

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 19245-19256

  Wu, Jin ^a   Zhong, Daixing ^b   Wu, Xinyu ^a   Sha, Mo ^a   Kang, Liangqi ^a   Ding, Zhenqi ^a  

^a Orthopaedic Center of People s Liberation Army   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell proliferation; Immunohistochemistry; Kv1.3; Osteosarcoma; shRNA

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; CASPASE 7; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POTASSIUM CHANNEL KV1.3; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; TUMOR PROMOTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; APOPTOSIS; BONE NEOPLASMS; CASPASE 3; CASPASE 7; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KV1.3 POTASSIUM CHANNEL; MICE; MICE, NUDE; OSTEOSARCOMA; POLY(ADP-RIBOSE) POLYMERASES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84884538414     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140919245     Document Type: Review

References (29)

1. Damron, T.A.; Ward, W.G.; Stewart, A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base report. Clin. Orthop. Relat. Res. 2007, 459, 40-47.
2. Sluga, M.; Windhager, R.; Pfeiffer, M.; Ofner, P.; Lang, S.; Dominkus, M.; Nehrer, S.; Zoubek, A.; Kotz, R. Osteosarcoma and Ewing's sarcoma-The most frequent malignant bone tumors in children-therapy and outcome. Z. Orthop. Ihre Grenzgeb. 2002, 140, 652-655.
3. Dorfman, H.A.; Czerniak, B. Bone cancers. Cancer 1995, 75, 203-210.
4. Panizo-Santos, A.; Sola, I.; Lozano, M; de Alava, E.; Pardo, J. Metastatic osteosarcoma presenting as a small bowel polyp: A case report and review of the literature. Arch. Pathol. Lab. Med. 2000, 124, 1682-1684.
5. Eppert, K.; Wunder, J.S.; Aneliunas, V.; Kandel, R.; Andrulis, I.L. von Willebrand factor expression in osteosarcoma metastasis. Mod. Pathol. 2005, 18, 388-397.
6. Wu, P.K.; Chen, W.M.; Chen, C.F.; Lee, O.K.; Haung, C.K.; Chen, T.H. Primary osteogenic sarcoma with pulmonary metastasis: Clinical results and prognostic factors in 91 patients. Jpn. J. Clin. Oncol. 2009, 39, 514-522.
7. Ferrari, S.; Pieretti, F.; Verri, E. Perspective evaluation of renal fuction in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate. Anticancer Drugs 2005, 16, 733-738.
8. + channels in regulating tumour cell proliferation and apoptosis. Pflug. Arch. 2004, 448, 274-286.
9. Pardo, L.A. Voltage-gated potassium channels in cell proliferation. Physiology 2004, 19, 285-292.
10. Felipe, A.; Vicente, R.; Villalonga, N.; Roura-Ferrer, M.; Martinez-Marmol, R.; Sole, L.; Ferreres, J.C.; Condom, E. Potassium channels:new targets in cancer therapy. Cancer Detect. Prev. 2006, 30, 375-385.
11. + channel gene. Proc. Natl. Acad. Sci. USA 1990, 87, 9411-9415.
12. Szabo, I.; Bock, J.; Grassme, H.; Soddemann, M.; Wilker, B.; Lang, F.; Zoratti, M.; Gulbins, E. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 2008, 105, 14861-14866.
13. Cahalan, M.D.; Chandy, K.G. The functional network of ion channels in T lymphocytes. Immunol. Rev. 2009, 231, 59-87.
14. Szabo, I.; Adams, C.; Gulbins, E. Ion channels and membrane rafts in apoptosis. Pflug. Arch. 2004, 448, 304-312.
15. Szabo, I.; Zoratti, M.; Gulbins, E. Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 2010, 584, 2049-2056.
16. (+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 2009, 42, 535-539.
17. Lan, M.; Shi, Y.; Han, Z.; Hao, Z.; Pan, Y.; Liu, N.; Guo, C.; Hong, L.; Wang, J.; Qiao, T.; et al. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol. Ther. 2005, 4, 1342-1347.
18. Preussat, K.; Beetz, C.; Schrey, M.; Kraft, R.; Wolfl, S.; Kalff, R.; Patt, S. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 2003, 346, 33-36.
19. Abdul, M.; Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett. 2002, 186, 99-105.
20. (+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. Curr. Med. Chem. 2012, 19, 661-674.
21. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
22. Emerson, M. Kv1.3: The perfect opening of the platelet voltage gate. J. Physiol. 2010, 588, 1809.
23. Bielanska, J.; Hernandez-Losa, J.; Perez-Verdaguer, M.; Moline, T.; Somoza, R.; Ramon, Y.; Cajal, S.; Condom, E.; Ferreres, J.C.; Felipe, A. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr. Cancer Drug Targets 2009, 9, 904-914.
24. Abdul, M.; Santo, A.; Hoosein, N. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 2003, 23, 3347-3351.
25. + channels are associated with cell proliferation and cell cycle of ovarian cancer cell. Gynecol. Oncol. 2007, 104, 455-460.
26. Jang, S.H.; Choi, S.Y.; Ryu, P. D; Lee, S.Y. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur. J. Pharmacol. 2011, 651, 26-32.
27. Leanza, L.; Henry, B.; Sassi, N.; Zoratti, M.; Chandy, K.G.; Gulbins, E.; Szabo, I. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol. Med. 2012, 4, 577-593.
28. Youn, C.K.; Song, P.I.; Kim, M.H.; Kim, J.S.; Hyun, J.W.; Choi, S.J.; Yoon, S.P.; Chung, M.H.; Chang, I.Y.; You, H.J. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts. Mol. Cancer Res. 2007, 5, 1083-1098.
29. Wu, J.; Wu, X.; Zhong, D.; Zhai, W.; Ding, Z.; Zhou, Y. Short hairpin RNA (shRNA) ether a go-go 1 (Eag1) inhibition of human osteosarcoma angiogenesis via VEGF/PI3K/AKT signaling. Int. J. Mol. Sci. 2012, 13, 12573-12583.